Today: 31 January 2026
Subscribe
Browse Category

Healthcare News 25 January 2026 - 29 January 2026

Humana stock bounces after Medicare Advantage rate shock; what traders are watching next

Humana stock bounces after Medicare Advantage rate shock; what traders are watching next

New York, Jan 29, 2026, 14:25 EST — Regular session Humana Inc. shares gained roughly 1.5%, reaching $196.94 by Thursday afternoon, following a close of $194.01 on Wednesday. The stock has struggled to stabilize after U.S. regulators suggested a 2027 Medicare Advantage payment increase that fell well short of expectations—a crucial revenue source for major insurers. Baird analyst Michael Ha…
29 January 2026
····
Walmart stock price rises after pharmacy pay boost as investors eye healthcare push (WMT)

Walmart stock price rises after pharmacy pay boost as investors eye healthcare push (WMT)

New York, Jan 29, 2026, 12:45 EST — Regular session Walmart Inc shares ticked up Thursday following a boost in pay opportunities for thousands of pharmacy technicians, highlighting the retailer’s push deeper into healthcare and delivery. By 12:30 p.m. EST, Walmart climbed roughly 0.7% to $117.39. The pay hike is significant since pharmacy relies heavily on labor, and labor costs…
29 January 2026
·····
Humana stock sinks again as Medicare Advantage rate shock keeps HUM under pressure

Humana stock sinks again as Medicare Advantage rate shock keeps HUM under pressure

New York, January 28, 2026, 21:11 EST — Market closed Humana (HUM.N) shares fell 6.69% to close at $194.01 on Wednesday, deepening losses amid a broader selloff triggered by U.S. Medicare Advantage payment proposals. (Finviz) This move is significant since Humana relies heavily on Medicare Advantage, the private plans that substitute traditional Medicare. The government’s yearly payment update directly influences…
29 January 2026
····
Humana stock slides again as Medicare Advantage rate proposal keeps pressure on insurers

Humana stock slides again as Medicare Advantage rate proposal keeps pressure on insurers

New York, January 28, 2026, 12:35 (EST) — Regular session Shares of Humana Inc dropped roughly 6% on Wednesday, extending the insurer’s struggles following a steep two-day selloff in Medicare Advantage-related health plans. The stock slipped to $195.31, down 6.1%, after starting the day at $206.51. This matters because Humana ranks among the insurers most tied to Medicare Advantage, the…
28 January 2026
····
CVS stock rebounds after Medicare Advantage rate scare; what investors watch next

CVS stock rebounds after Medicare Advantage rate scare; what investors watch next

NEW YORK, Jan 28, 2026, 11:46 EST — Regular session Shares of CVS Health Corporation climbed roughly 3% on Wednesday, recovering some ground after a sharp drop linked to new U.S. government proposals affecting Medicare Advantage payments. By late morning, the stock had gained 3.1%, reaching $74.22. The rebound follows CVS’s close at $72.00 on Tuesday, marking a 14.15% drop…
28 January 2026
·····
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

NEW YORK, Jan 27, 2026, 20:02 (ET) — Market closed. Elevance Health, Inc. shares plunged Tuesday, ending down 14.3% at $322.92 after hours. The drop came as investors dumped U.S. health insurers following a Medicare Advantage rate proposal that missed Wall Street’s forecasts by a wide margin. The timing is crucial. The rate notice arrives right as managed-care firms enter…
28 January 2026
····
CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next

CVS stock price dives 14% after CMS Medicare Advantage rate proposal; what investors watch next

New York, Jan 27, 2026, 17:51 EST — After-hours CVS Health Corp (CVS.N) shares slid roughly 14% to $72 in after-hours trading Tuesday, after a U.S. Medicare payment proposal prompted a sharp reevaluation of health insurer earnings. The stock fluctuated between $70.77 and $77.08, with volume surpassing 44 million shares. On Monday, the Centers for Medicare & Medicaid Services unveiled…
28 January 2026
····
ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

NEW YORK, January 27, 2026, 14:52 EST — Regular session Shares of Intuitive Surgical, Inc. slipped 0.7% to $525.09 Tuesday, despite a fresh U.S. approval for its newest da Vinci 5 surgical robot. Meanwhile, the broader market moved higher, with the S&P 500 ETF (SPY) gaining roughly 0.5% and the Nasdaq-focused QQQ rising about 0.9%. Just a day earlier, Intuitive…
27 January 2026
······
Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

New York, January 27, 2026, 06:00 EST — Premarket U.S. stock index futures edged up early Tuesday as investors prepared for a heavy earnings slate and the Federal Reserve’s first policy announcement of the year. Health insurers took a hit following a Medicare Advantage payment proposal. At 5:22 a.m. ET, S&P 500 E-mini futures rose 0.25%, Nasdaq 100 E-minis gained…
27 January 2026
·····
Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

New York, January 26, 2026, 14:55 EST — Regular session Shares of Boston Scientific Corp climbed 1.7% to $94.12 Monday afternoon, gaining $1.61 since Friday’s close. The stock fluctuated between $92.03 and $94.24, with roughly 5.4 million shares traded by mid-afternoon. Boston Scientific is gearing up to release its fourth-quarter and full-year 2025 results on Feb. 4. Investors will be…
26 January 2026
·····
Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

New York, Jan 25, 2026, 13:19 ET — Market closed Healthcare stocks finished last week lower, with XLV — the ETF tracking major U.S. healthcare companies — slipping 0.5% by Friday’s close. Eli Lilly weighed on the sector, though some of the bigger names in the index managed to hold up. The drop followed a choppy week for the broader…
25 January 2026
········
Abbott stock price: ABT heads into Monday after a two-day slide on nutrition worries

Abbott stock price: ABT heads into Monday after a two-day slide on nutrition worries

New York, January 24, 2026, 17:34 EST — Market closed Abbott Laboratories shares ended Friday at $107.42, slipping 1.1% after tumbling nearly 10% the previous day. Investors are reacting to a quarterly sales shortfall and a weaker 2026 forecast. When trading resumes Monday, the nutrition segment remains the primary concern for many analysts. (Investing) Abbott reported a 4.4% rise in…
25 January 2026
·····
1 2 3 … 12

Stock Market Today

  • Plug Power Stock Analysis: Deep-Value Potential or High-Risk Investment?
    January 31, 2026, 11:36 AM EST. Plug Power (PLUG) has lost 97% of its value over five years despite ambitions to build a zero-carbon hydrogen energy ecosystem. The company faces massive losses, including $2.1 billion net loss and $518 million cash burn over the past 12 months, raising concerns about its financial sustainability. While its electrolyzer market opportunity could grow from under $2 billion in 2023 to $40 billion by 2032, Plug Power's current market cap exceeds $2.9 billion, reflecting significant investor risk. The stock's volatile performance suggests caution, with potential for further declines amid uncertain profitability and ongoing cash needs. Investors should weigh the sizeable financial risks against long-term growth prospects in the hydrogen energy sector carefully.
Go toTop